New Drug Approvals






Flag Counter

National Medical Products Administration

National Medical Products Administration (国家药品监督管理局)
China Food and Drug Administration Badge.PNG
Formation 1950 (predecessor organization)
2018 (latest re-organization)
Type Ministry-level regulatory body
Headquarters 26-Yuan, Xuanwumen Avenue West, Xicheng District, Beijing
  • Beijing, China
Bi Jingquan
Deputy Directors
Yin Li, Wang Mingzhu, Teng Jiacai, Wu Zhen, Jiao Hong
Discipline Inspection Leader
Li Wusi
Parent organization
State Administration for Market Regulation
Affiliations Commission on Food Safety

The National Medical Products Administration (NMPA)[1] (Chinese国家药品监督管理局) (formerly the China Food and Drug Administration, or CFDA) was founded on the basis of the former State Food and Drug Administration (SFDA). In March 2013, the former regulatory body was rebranded and restructured as the China Food and Drug Administration, elevating it to a ministerial-level agency.[2] In 2018, as part of China’s 2018 government administration overhaul, the name was changed to ‘National Medical Products Administration’ and merged into the newly-created State Administration for Market Regulation.[3] The headquarters are in Xicheng DistrictBeijing.[4]

In its first incarnation as the CFDA, the NMPA replaced a large group of overlapping regulators with an entity similar to the Food and Drug Administration of the United States, streamlining regulation processes for food and drug safety.[5] The National Medical Products Administration is directly under the State Council of the People’s Republic of China, which is in charge of comprehensive supervision on the safety management of food, health food and cosmetics and is the competent authority of drug regulation in mainland China.[6]

On 10 July 2007, Zheng Xiaoyu, the former head of China’s State Food And Drug Administration, was executed for taking bribes from various firms in exchange for state licences related to product safety.[7]

Main responsibilities

Draft laws, regulations and rules and policy plans on the administration and supervision of food (including food additives and health food, the same below) safety, drugs (including traditional Chinese medicines and ethno-medicines, the same below), medical devices and cosmetics; formulate normative documents, and facilitate the establishment and implementation of the food safety responsibility mechanism, under which food companies shall bear the main responsibility and local people’s governments shall take integrated responsibility; establish the direct reporting system for critical food and drug information and supervise its implementation; take measures to reduce risks on regional and systemic food and drug safety;

Formulate the regulations on food administrative licensing and supervise their implementation; establish food safety risk management mechanism, formulate annual plans for nationwide inspection for food safety and programs for major control actions, and organize their implementation; establish the unified food safety information release system and release information on important food safety issues; participate in formulating food safety risk monitoring plans and food safety standards, and undertake food safety risk monitoring thereon;

Organize the formulation and publication of the national pharmacopeia, other drug and medical device standards and classification system, and supervise their implementation; develop good practices on research, production, distribution and use of drugs and medical devices, and supervise their implementation; undertake drug and medical device registration, supervision and inspection; establish monitoring system for adverse drug reactions, adverse events of medical devices, and undertake monitoring and response activities; draw up and improve regulations and qualifications for licensed pharmacists, guide and supervise the registration work; participate in formulating national essential medicine list and assist its implementation; formulate administrative provisions for cosmetics administration and supervise their implementation;

Formulate the investigation and enforcement system for food, drugs, medical devices and cosmetics, and organize their implementation; organize the investigation and punishment on major violations; establish recall and disposal system for defect products, and supervise the implementation;

Establish food and drug emergency response system, organize and guide the emergency response and investigation on food and drug safety incident, and supervise the implementation of investigation and punishment;

Formulate science and technology development plans for food and drug safety, and organize their implementation; accelerate the construction of food and drug testing system, electronic supervision tracking system, and information system;

Undertake the public communication, education and training, and international exchanges and cooperation in the field of food and drug safety; promote the establishment of credibility system;

Guide food and drug administration works of local governments, regulate administrative activities, and improve the interlocking mechanism between administrative enforcement and criminal justice;[8]

Undertake the routine work of the Food Safety Commission of the State Council; take charge of comprehensive coordination on food safety administration, facilitate and improve the cooperation and coordination mechanism; supervise the work of provincial people’s governments on food safety administration, and evaluate their performance;

Undertake other work assigned by the State Council and the Food Safety Commission of the State Council.

Registration for medical devices

The NMPA is responsible for registration of medical devices for the Chinese market. All medical devices have to be classified by the CFDA according to its risk in three classes. Depending on the risk classification, different aspects are required:

  • For medical devices of class I: product tests are sometimes required
  • For medical devices of class II: product tests are always required and clinical trials are sometimes required
  • For medical devices of class III: product tests are always required

Organizational structure

Internal structure of CFDA (forerunner of NMPA)[9]

  1. General Office
  2. Dept. of Legal Affairs
  3. Dept. of Food Safety Supervision (I – III)
  4. Dept. of Drug and Cosmetics Registration (Dept. of TCMs and Ethno-Medicines Supervision)
  5. Dept. of Medical Device Registration
  6. Dept. of Drug Cosmetics Supervision
  7. Dept. of Medical Device Supervision
  8. Bureau of Investigation and Enforcement
  9. Dept. of Emergency Management
  10. Dept. of Science, Technology and Standards
  11. Dept. of Media and Publicity
  12. Dept. of Human Resources
  13. Dept. of Planning and Finance
  14. Dept. of International Cooperation (Office of Hong Kong, Macao and Taiwan Affairs)


  • Mr Bi Jingquan (Director)
  • Mr Yin Li (Deputy Director)
  • Ms Wang Mingzhu (Deputy Director)
  • Mr Teng Jiacai (Deputy Director)
  • Mr Wu Zhen (Deputy Director)
  • Ms Jiao Hong (Deputy Director)
  • Mr Li Wusi (Head of discipline inspection group)
  • Mr Sun Xianze (Assistant Director for Drug Safety)
  • Mr Guo Wenqi (Assistant Director for Food Safety)

Standards and regulations

The medical devices regulatory system is based on regulations issued by the State Council, NMPA orders and NMPA documents that provide detailed rules for medical device registration and licensing practice.[10] Medical device type testing must be based upon the Chinese National Standard (Chinese: Guobiao, GB) or at least on an Industry Standard (YY). The system is undergoing frequent changes and adjustments. In October 2013, more than 104 new YY Standards were released.


Only 100 new drugs were approved between 2001 and 2016, about a third of the number in most Western countries. Approval times have been cut from six to seven years down to two or three years and data from overseas clinical trials is now accepted.[11]

See also


  1. ^ “NMPA”.
  2. ^ “China gets stronger food, drug regulator.” China Daily, Xinhua. 22 March 2013.
  3. ^ Lack of ‘general rules’ slowing progress in China’s cosmetics industry,
  4. ^ Contact CFDA.” China Food and Drug Administration. Retrieved on August 18, 2016. “Address: 26 Xuanwumen Xidajie, Beijing, 100053, P.R. China” Chinese addressArchived 2016-08-17 at the Wayback Machine: “地址:北京市西城区宣武门西大街26号院2号楼”
  5. ^ “China to elevate food, drug agency to general administration.” 10 March 2013. Xinhua.
  6. ^ “Consolidation of the China Food and Drug Administration,” by Nick Beckett and David Pountney. CMS Cameron McKenna. 3 June 2013.
  7. ^ China food safety head executed
  8. ^ “New procedures released for medical device registration in China,”
  9. ^ “CFDA organizational structure”. Retrieved 2014-12-29.
  10. ^ “CFDA: An Update on the Regulatory Process in China”. European Medical Device Technology. Retrieved 2015-06-16.
  11. ^ “In China, Desperate Patients Smuggle Drugs. Or Make Their Own”The New York Times. 11 November 2018. Retrieved 22 December 2018.

Further reading

  • Dali Yang, “Regulatory Learning and Its Discontents in China: Promise and Tragedy at the State Food and Drug Administration,” in John Gillespie and Randall Peerenboom, eds., Pushing Back Globalization, Routledge, 2009.

External links

Blog Stats

  • 4,301,238 hits

Flag and hits

Flag Counter


Read all about Organic Spectroscopy on ORGANIC SPECTROSCOPY INTERNATIONAL 

Enter your email address to follow this blog and receive notifications of new posts by email.

Join 2,821 other subscribers
Follow New Drug Approvals on


DR ANTHONY MELVIN CRASTO, Born in Mumbai in 1964 and graduated from Mumbai University, Completed his Ph.D from ICT, 1991,Matunga, Mumbai, India, in Organic Chemistry, The thesis topic was Synthesis of Novel Pyrethroid Analogues, Currently he is working with AFRICURE PHARMA, ROW2TECH, NIPER-G, Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, Govt. of India as ADVISOR, earlier assignment was with GLENMARK LIFE SCIENCES LTD, as CONSUlTANT, Retired from GLENMARK in Jan2022 Research Centre as Principal Scientist, Process Research (bulk actives) at Mahape, Navi Mumbai, India. Total Industry exp 32 plus yrs, Prior to joining Glenmark, he has worked with major multinationals like Hoechst Marion Roussel, now Sanofi, Searle India Ltd, now RPG lifesciences, etc. He has worked with notable scientists like Dr K Nagarajan, Dr Ralph Stapel, Prof S Seshadri, etc, He did custom synthesis for major multinationals in his career like BASF, Novartis, Sanofi, etc., He has worked in Discovery, Natural products, Bulk drugs, Generics, Intermediates, Fine chemicals, Neutraceuticals, GMP, Scaleups, etc, he is now helping millions, has 9 million plus hits on Google on all Organic chemistry websites. His friends call him Open superstar worlddrugtracker. His New Drug Approvals, Green Chemistry International, All about drugs, Eurekamoments, Organic spectroscopy international, etc in organic chemistry are some most read blogs He has hands on experience in initiation and developing novel routes for drug molecules and implementation them on commercial scale over a 32 PLUS year tenure till date Feb 2023, Around 35 plus products in his career. He has good knowledge of IPM, GMP, Regulatory aspects, he has several International patents published worldwide . He has good proficiency in Technology transfer, Spectroscopy, Stereochemistry, Synthesis, Polymorphism etc., He suffered a paralytic stroke/ Acute Transverse mylitis in Dec 2007 and is 90 %Paralysed, He is bound to a wheelchair, this seems to have injected feul in him to help chemists all around the world, he is more active than before and is pushing boundaries, He has 100 million plus hits on Google, 2.5 lakh plus connections on all networking sites, 100 Lakh plus views on dozen plus blogs, 227 countries, 7 continents, He makes himself available to all, contact him on +91 9323115463, email, Twitter, @amcrasto , He lives and will die for his family, 90% paralysis cannot kill his soul., Notably he has 38 lakh plus views on New Drug Approvals Blog in 227 countries...... , He appreciates the help he gets from one and all, Friends, Family, Glenmark, Readers, Wellwishers, Doctors, Drug authorities, His Contacts, Physiotherapist, etc He has total of 32 International and Indian awards

Personal Links

Verified Services

View Full Profile →


%d bloggers like this: